Jianjun Zhang

78PUBLICATIONS
487CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCarbon capture engineering (excl. sequestration)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (78)

|Jul 08, 2026
Unbiased avidity-based isolation of antigen-specific T cells.

|Jun 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing.

|May 18, 2026
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

|Mar 19, 2026
FOXM1-Specific TCR-Engineered T Cells Target Non-Small Cell Lung Cancer.

Emily Bontekoe, Minying Zhang, Peixin Jiang

|Mar 11, 2026
Author Correction: Innovative approaches for lung cancer screening and interception.

Jianjun Zhang, Matthew D Park, Tej Pandya

Pageof 13

Frequent Collaborators

39 joint publications

John Victor Heymach

29 joint publications

Jack Lee

28 joint publications

Don L Gibbons

27 joint publications

Jia Wu